Megan Montgomery

Megan Montgomery serves as the Senior Director of Medical Communications and Information at Nuvalent, Inc. since November 2024. Previously, Megan held the position of Executive Director of Publications and Communications at Syndax Pharmaceuticals, where contributions included shaping medical strategy and overseeing the launch of two therapeutic products. Other roles include Director of Scientific Publications and Medical Communications at Clovis Oncology, and various roles at Amarin Corporation, culminating as Senior Medical Science Liaison. As a co-founder of AdrenaRx, Megan focused on transitioning a novel pharmacological target for cardiovascular disease into commercial development. Educational credentials include a PhD in Pharmacology from the University of Nebraska Medical Center and a B.S. in Biology from Fort Hays State University.